J. J. Lee

Active 1983–2026

Also published as
J J Lee · J.J. Lee · J-J Lee · J.-J. Lee · J.J Lee · J. -J Lee · J.J. LEE
119
Papers
20,432
Citations
86
h-index
110
i10-index

Citations

Citations per year for J. J. Lee1905: 1 citations1984: 1 citations1985: 1 citations1986: 1 citations1987: 4 citations1988: 6 citations1989: 7 citations1990: 13 citations1991: 10 citations1992: 19 citations1993: 28 citations1994: 39 citations1995: 66 citations1996: 73 citations1997: 113 citations1998: 111 citations1999: 188 citations2000: 187 citations2001: 192 citations2002: 194 citations2003: 202 citations2004: 156 citations2005: 141 citations2006: 157 citations2007: 101 citations2008: 127 citations2009: 128 citations2010: 104 citations2011: 146 citations2012: 114 citations2013: 156 citations2014: 142 citations2015: 136 citations2016: 132 citations2017: 125 citations2018: 141 citations2019: 407 citations2020: 339 citations2021: 315 citations2022: 250 citations2023: 178 citations2024: 236 citations2025: 103 citations2026: 5 citations1906–1983: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,240 citing papers, 32% of this breakdownChina: 527 citing papers, 7.5% of this breakdownUnited Kingdom: 470 citing papers, 6.7% of this breakdownGermany: 321 citing papers, 4.6% of this breakdownItaly: 252 citing papers, 3.6% of this breakdownJapan: 239 citing papers, 3.4% of this breakdownCanada: 232 citing papers, 3.3% of this breakdownNetherlands: 229 citing papers, 3.3% of this breakdownAustralia: 216 citing papers, 3.1% of this breakdownFrance: 201 citing papers, 2.9% of this breakdownSouth Korea: 176 citing papers, 2.5% of this breakdownSpain: 150 citing papers, 2.2% of this breakdown
0%32%Other 24.9%

Fields

  • Medicine45.3%
  • Biochemistry, Genetics and Molecular Biology20.4%
  • Computer Science8.6%
  • Immunology and Microbiology6.7%
  • Engineering3.6%
  • Psychology2.8%
  • Other12.6%

Topics

  • Asthma and respiratory diseases2.3%
  • Lung Cancer Treatments and Mutations1.8%
  • Innovative Human-Technology Interaction1.8%
  • Cancer-related Molecular Pathways1.7%
  • Immune Cell Function and Interaction1.7%
  • Cancer survivorship and care1.3%
  • Other89.4%

Coauthors

All papers

Open in search
  1. International Journal of Design

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , A Deserti, F Rizzo, A Dumas, H Mintzberg, D Dunne, R Martin, M Ferreira, A Botero, F Fischer, Foucault, K Hakio, T Mattelmki, K Hakio, T Mattelmki, P Hannukainen, M Kiirikki, T Manninen, L Skkinen, S Holmlid, Malmberg, J Hyvrinen, J. -J Lee, T Mattelmki, V Hyysalo, S Hyysalo, S Hyysalo, V Hyysalo, L Hakkarainen, S Hyysalo, K Savolainen, A Pirinen, T Mattelmki, T Jensen, M Petersen, G Julier, G Julier, M Leerberg, S Junginger, S Junginger, S Junginger, S Junginger, D Sangiorgi, S Junginger, D Sangiorgi, L Kimbell, J Bailey, C Kohtala, S Hyysalo, J Whalen, T Komatsu, M Salgado, A Deserti, F Rizzo, M Mcgann, E Blomkamp, J Lewis, M Mcgann, T Wells, E Blomkamp, I Mergel, A Meyer, S Park-Lee, O Person, B Pfaffenberger, A Pirinen, N Rantisi, D Leslie, N Rebolledo, -N Sanders, P Stappers and 23 more - International Journal of Design 2021 cited by 1,614

  2. Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen G. Swisher, Tina Cascone, John V. Heymach, J. Zhang, Boris Sepesi, Don L. Gibbons, Chantale Bernatchez - Annals of Oncology 2021 cited by 136

  3. Larotrectinib in adult patients with solid tumours: a multi-centre, open-label, phase I dose-escalation study

    Authors: , , , , , , , , , , , , , , , , - Annals of Oncology 2019 cited by 153

  4. The KNee OsteoArthritis Prediction (KNOAP2020) challenge: An image analysis challenge to predict incident symptomatic radiographic knee osteoarthritis from MRI and X-ray images

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Edwin H. G. Oei, Stefan Klein - Osteoarthritis and Cartilage 2022 cited by 60

  5. Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashraf Badros, Philippe Moreau, K Kim, P R Otero, J H Lee, Chaim Shustik, Daniel D. Waller, Wee Joo Chng, Shuji Ozaki, J-J Lee, Javier de la Rubia, Hyeon‐Seok Eom, Laura Rosiñol, Juan José Lahuerta, Anna Sureda, Jin Seok Kim, B G M Durie - Leukemia 2017 cited by 354

  6. Suppressed immune microenvironment and repertoire in brain metastases from patients with resected non-small-cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Annals of Oncology 2019 cited by 153

  7. Eosinophils in health and disease: the LIAR hypothesis

    Authors: , , , , - Clinical & Experimental Allergy 2010 cited by 336

  8. PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation

    Authors: , , , , , , , , - Cell Death and Differentiation 2010 cited by 173

  9. Kaempferol‐induced growth inhibition and apoptosis in A549 lung cancer cells is mediated by activation of MEK‐MAPK

    Authors: , , , , , , , , , , - Journal of Cellular Physiology 2003 cited by 176

  10. Identification of the Retinoic Acid-Inducible Gprc5a As a New Lung Tumor Suppressor Gene

    Authors: , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2007 cited by 125

  11. A Three Dimensional DRAM (3D DRAM) Technology for the Next Decades

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , S. B. Kim, K. H. Lee, S. O. Chung, S. S. Kim, I. S. Jin, B. K. Lee, C. W. Kim, Joodong Park, S. Y. Cha - IEEE Symposium on VLSI Technology and Circuits (VLSI Technology and Circuits) 2024 cited by 42

  12. Gene Expression Changes and Early Events in Cotton Fibre Development

    Authors: , , - Annals of Botany 2007 cited by 370

  13. Epidermal growth factor receptor regulates MET levels and invasiveness through hypoxia-inducible factor-1α in non-small cell lung cancer cells

    Authors: , , , , , , , , , , , , , , , , , , - Oncogene 2010 cited by 94

  14. Predicting cancer development in oral leukoplakia: ten years of translational research.

    Authors: , , , , , , , , , , , , , , - 2000 cited by 428

  15. Expression of IL-5 in thymocytes/T cells leads to the development of a massive eosinophilia, extramedullary eosinophilopoiesis, and unique histopathologies

    Authors: , , , , , - The Journal of Immunology 1997 cited by 239

  16. Gender differences in treatment outcomes of tuberculosis patients in Taiwan: a prospective observational study

    Authors: , , , , , , , , , , , , - Clinical Microbiology and Infection 2012 cited by 112

  17. Bacteriophage in-feed application: A novel approach to preventing Salmonella Enteritidis colonization in chicks fed experimentally contaminated feed

    Authors: , , , , , , , , - The Journal of Applied Poultry Research 2020 cited by 21

  18. Dietary plant extracts alleviate diarrhea and alter immune responses of weaned pigs experimentally infected with a pathogenic Escherichia coli1

    Authors: , , , , , , , - Journal of Animal Science 2013 cited by 154

  19. Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma

    Authors: , , , , , , , , , , , , - Annals of Oncology 2006 cited by 121

  20. Characterization of an Isogenic Mutant of Streptococcus pyogenes Manfredo Lacking the Ability To Make Streptococcal Acid Glycoprotein

    Authors: , , , , , , , - Infection and Immunity 2000 cited by 119

  21. Eosinophil peroxidase in sputum represents a unique biomarker of airway eosinophilia

    Authors: , , , , , , - Allergy 2013 cited by 99

  22. Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma

    Authors: , , , , , , , , , , , - Annals of Oncology 2015 cited by 85

  23. Retrovirus–mediated wild–type P53 gene transfer to tumors of patients with lung cancer.

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 1996 cited by 703

  24. Cyclooxygenase-2 overexpression is a marker of poor prognosis in stage I non-small cell lung cancer.

    Authors: , , , , , , , , - 2001 cited by 412